| Laszczewska Maja |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Abu Bakar Nur Dianah |
Exploring Aspirin's Role in Mitigating Liver Cancer Development: Insights from a NASH Mouse Model
|
| Ajouaou Yousra |
Epigenetic regulation by UHRF1 in the aging liver
|
| Algueró Nadal Ana |
NASH has a tumor-suppressive effect through Yap driven cell competition
|
| Amaya LUJAMBIO |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Arconzo Maria |
Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
|
| Arslanow Anita |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Assen Frank |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Augustin Hellmut |
Mechanosensitive self-fueling vascular Wnt controls liver function
|
| Barcena-Varela Marina |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
|
| Bataller Ramon |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
|
| Baweja Sukriti |
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
|
| Behrmann Iris |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Bihari Chhagan |
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
|
| Bissig Karl-Dimiter |
Correcting metabolic liver disease by gene therapy
|
| Brzozwoska Natalia |
Somatic mutations in steatotic liver disease lead to hepatic metabolic remodelling
|
| Bujko Ania |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Calderaro Julien |
Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
|
| Califano Andrea |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
|
| Cameron Rainie |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Campbell Peter |
Somatic mutations in steatotic liver disease lead to hepatic metabolic remodelling
|
| Carlessi Rodrigo |
Novel pre-malignant hepatocyte state (daHep) accumulates in liver disease and predicts HCC risk
|
| Caruso Stefano |
Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
|
| Casado Marta |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
|
| Casper Markus |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Céline POPHILLAT |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Chantal DESDOUETS |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Chen Zhen |
Injury-induced hepatocyte dedifferentiation in liver regeneration and tumorigenesis
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
|
| Christelle KABORE |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Collins Amy |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Cordier Pierre |
Polyploidy, DNA damage response driver or gatekeeper of chronic liver diseases
|
| Cucarella Carme |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
|
| Dalgarno Kenny |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| De Ponti Federico |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Delpierre Julien |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Desdouets Chantal |
Polyploidy, DNA damage response driver or gatekeeper of chronic liver diseases
|
| Donne Romain |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
|
| Dooley Steven |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Dowbaj Anna |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Duncan Stephen |
Understanding the Role of HNF1B in the Transition of the Endoderm to a Hepatic Fate
|
| Dwyer Benjamin |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Ebert Matthias |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Fan Weiguo |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Fernandez Mercedes |
Translational control in liver disease
|
| Filliol Aveline |
Regulation of hepatocyte functions by hepatic stellate cells in health and disease
|
| Fuertes-Agudo Marina |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
|
| Gaigneaux Anthoula |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Geh Daniel |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Ghaffari Laleh Narmin |
Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
|
| Go Shirley |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Halder Georg |
NASH has a tumor-suppressive effect through Yap driven cell competition
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and Cancer
|
| Hatzigeogriou Artemis |
Pathway analysis including miRNA function.
|
| He Shirui |
Identifying drivers of liver cancer using CRISPR activation screening in vivo
|
| Heikenwälder Mathias, |
Characterization of a novel Er stress inducing oncoprotein that restricts immunosurveillance
|
| Henderson Neil |
Multimodal decoding of human liver regeneration
|
| Ho Yu-jui |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
|
| Hoek Jan |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
|
| Hofer Benedikt |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Holmes Alan` |
Disease-specific human ECM composition and bioactivity in NASH liver fibrosis
|
| Huch Meritxell |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Hui Lijian |
Injury-induced hepatocyte dedifferentiation in liver regeneration and tumorigenesis
|
| Hylemon Phillip |
Dysregulated sphingolipid metabolism in MASH-HCC
|
| Inverso Donato |
Vascular Control of Liver Pathobiology
|
| Jean-Pierre COUTY |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Jessica ZUCMAN-ROSSI |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Jing FANG |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Joana ARAUJO |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Kain Renate |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Kaltenecker Christopher |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Kardaras Filippos |
Pathway analysis including miRNA function.
|
| Karpale Mikko |
The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
|
| Kather Jakob |
Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
|
| Kirchmeyer Mélanie |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Koche Richard |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
|
| Koivunen Peppi |
The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
|
| Kondylis Vangelis |
A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
|
| Königshofer Philipp |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Krawczyk Marcin |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Kuehn Ariane |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Lammert Frank |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Landerer Cedric |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Leclercq Isabelle |
the niche map of ductular reaction-driven regeneration
|
| Lee Markcus |
Identifying drivers of liver cancer using CRISPR activation screening in vivo
Mechanosensitive self-fueling vascular Wnt controls liver function
|
| Leedman Peter |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Leslie Jack |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Li Yujia |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Liebling Ian |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
|
| Lindblad Kathrenine |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
|
| Link Frederik |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Long PAN |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Longato Lisa |
Disease-specific human ECM composition and bioactivity in NASH liver fibrosis
|
| Lowe Scott |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Targeting senescence mechanisms in liver fibrosis and cancer
|
| Lozano Anthony |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
|
| Luedde Tom |
How programmed cell death and cell death responses control HCC development
|
| Lujambio Amaia |
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Notch1 promotes sexually dimorphic immune responses in HCC
|
| Luque-Tévar María |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
|
| Macchi Filippo |
Epigenetic regulation by UHRF1 in the aging liver
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
|
| Magnani Elena |
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
|
| Mahadevan Radhakrishnan |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
|
| Manchel Alexandra |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
|
| Manco Rita |
the niche map of ductular reaction-driven regeneration
|
| Mandorfer Matthias |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
|
| Mann Derek |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Martens Liesbet |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Martín-Sanz Paloma |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
|
| Martinez-Morant Carla |
Understanding the Role of HNF1B in the Transition of the Endoderm to a Hepatic Fate
|
| Matchett Kylie |
Multimodal decoding of human liver regeneration
|
| Matrella Maria Laura |
Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
|
| McBain Ian |
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
|
| Merens Vincent |
Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
|
| Miliotis Marios |
Pathway analysis including miRNA function.
|
| Mol Hasse |
NASH has a tumor-suppressive effect through Yap driven cell competition
|
| Moschetta Antonio |
Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
|
| Moschopoulou Athina |
Development and characterization of kinase sparing TPX2-tethering Aurora Kinase A ligands for cancer therapy
|
| Moya Ivan |
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and Cancer
|
| Mozayani Behrang |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Munker Stefan |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Murali Rajmohan |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
|
| Nair Ajay |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
|
| Neirynck Gauthier |
the niche map of ductular reaction-driven regeneration
|
| Nelson Glyn |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Niksic Armin |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Nwosu Zeribe |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Oakley Fiona |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Pajvani Utpal |
Maladaptive re-activation of morphogenic signaling in liver as causal to NASH-induced fibrosis
|
| Parmentier Fleur |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Pasic Sara |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Pasparakis Manolis |
A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
|
| Peiseler Moritz |
Visualizing Kupffer cell adaptations in liver fibrosis
|
| Petrenko Oleksandr |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
|
| Piccinin Elena |
Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
|
| Qiyuan HE |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Ramon-Gil Erik |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Reeves Helen |
The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
|
| Reiberger Thomas |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
|
| Romain DONNE |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| ruf Benjamin |
Deciphering Mucosal-Associated Invariant T (MAIT) Cell Regulation Networks in Liver Cancer
|
| Sadler Kirsten |
Epigenetic regulation of liver development, cancer & regeneration
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
|
| Sadler Edepli Kirsten |
Epigenetic regulation by UHRF1 in the aging liver
|
| Saito Yoshinobu |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
|
| Salgado Alexandra Vazquez |
Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
|
| Sarin Shiv |
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
|
| Schneider Anne |
How programmed cell death and cell death responses control HCC development
A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
|
| Schwabe Robert |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Regulation of hepatocyte functions by hepatic stellate cells in health and disease
|
| Schwabl Philipp |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
|
| Scott Charlotte |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Semmler Georg |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Sen Payel |
Epigenetic mechanisms of tissue aging
|
| Servais Florence |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
|
| Séverine MORIZUR |
Outcome of Targeting ATR in High Replication Stress Murine HCC
|
| Shirolkar Gayatri |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Siermala Sofia |
The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
|
| Simbrunner Benedikt |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Skoufos Giorgos |
Pathway analysis including miRNA function.
|
| Sljukic Aleksandra |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Sorz Thomas |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Steffani Marcella |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
|
| Subudhi P Debishree |
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
|
| Sun Qiuyan |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
CELL-TRANSPLANTATION-INDUCED REPROGRAMMING STATE IS ESSENTIAL FOR
HEPATOCYTE ENGRAFTMENT
|
| Talianidis Iannis |
The oncogenic function of Smyd3 histone methyltransferase in liver and colon cancer
|
| Tapiola Atte |
The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
|
| Taru Vlad |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
|
| Tastsoglou Spyros |
Pathway analysis including miRNA function.
|
| Tchorz Jan |
Game of zones: WNTer is coming
|
| Thangariyal Swati |
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
|
| Thone Tinne |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Tibballs Jonathan |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Tirnitz-Parker Nina |
Novel pre-malignant hepatocyte state (daHep) accumulates in liver disease and predicts HCC risk
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Trauner Michael |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Tsanov Kaloyan |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
|
| Vadigepalli Rajanikanth |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
|
| van Grunsven Leo |
Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
|
| Vanneste Bavo |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Vázquez Salgado Alexandra |
Identifying drivers of liver cancer using CRISPR activation screening in vivo
|
| Verhulst Stefaan |
Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
|
| Villani Gaetano |
Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
|
| Vujkovic Marijana |
Multiancestry genome-wide studies in nonalcoholic fatty liver disease studies
|
| Wallace Michael |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Waller Kathryn |
Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
|
| Wang Xuan |
Dysregulated sphingolipid metabolism in MASH-HCC
Epigenetic regulation by UHRF1 in the aging liver
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Wangensteen Kirk |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
Identifying drivers of liver cancer using CRISPR activation screening in vivo
|
| Way Rachel |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Weng Honglei |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
|
| Weninger Wolfgang |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Willenbring Holger |
Approaches to extending the reach of liver gene therapy
|
| Winteringham Louise |
Development of a precision bio-printed liver tumour patient-derived organoid platform
|
| Yin Dingzi |
Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
|
| Zender Lars |
Development and characterization of kinase sparing TPX2-tethering Aurora Kinase A ligands for cancer therapy
|
| Zeng Jing |
Dysregulated sphingolipid metabolism in MASH-HCC
Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
|
| Zerial Marino |
Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
|
| Zhao Derrick |
Dysregulated sphingolipid metabolism in MASH-HCC
|
| Zhou Huiping |
Dysregulated sphingolipid metabolism in MASH-HCC
|
| Zhu Changyu |
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
|
| Zinober Kerstin |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
|
| Zoppolato Elena |
NASH has a tumor-suppressive effect through Yap driven cell competition
|
| Zucman-Rossi Jessica |
Genetic predisposition to liver cancer
|
